Literature DB >> 31880663

Long-term Outcome of Transjugular Intrahepatic Portosystemic Shunt in Children With Portal Hypertension.

Angelo Di Giorgio1, Emanuele Nicastro1, Roberto Agazzi2, Mara Colusso3, Lorenzo D'Antiga1.   

Abstract

OBJECTIVES: A proportion of children with chronic liver disease have severe portal hypertension (PH) and a preserved synthetic and biliary function. In our institution these children have been managed with transjugular intrahepatic portosystemic shunts (TIPS). We aimed to evaluate the long-term patency of TIPS placed in pediatric patients with PH.
METHODS: Retrospective study of children who underwent TIPS in the last 15 years. We compared patients with cirrhotic PH to those with noncirrhotic PH, and all with an historical cohort of children who underwent a surgical portosystemic shunt. Kaplan-Meier analysis measured long-term shunt patency.
RESULTS: Twenty-nine patients were recorded (cirrhotic PH = 11, noncirrhotic PH  = 18, mean age 10.3 years[±4.3], mean weight 36.7 kg [±20.1], mean pediatric end-stage liver disease score 4.1 [±7.1]); in 5 TIPS was placed after split liver transplantation. Indication for TIPS was variceal bleeding in 18, refractory ascites in 11. Primary patency rates at 6 months and at 1, 2, and 4 years were 91%, 83%, 60%, and 46%, respectively. At last follow-up (mean of 2.8 years [±2.4, range 0.1-8.1 years]) secondary patency (after radiological revision) was 100%. The patency rate of the historical cohort of patients who underwent a surgical portosystemic shunt was 26 of 31 (82%) at a median follow-up of 12.5 years (1.6-25.8).
CONCLUSION: TIPS appears to have a high mid-term patency rate, especially if monitored and revised. Its high clinical success rate, along with a minimally invasive approach, suggests that in this setting TIPS should not be regarded only as a bridge to liver transplantation.

Entities:  

Mesh:

Year:  2020        PMID: 31880663     DOI: 10.1097/MPG.0000000000002597

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  3 in total

1.  Transjugular intrahepatic portosystemic shunt creation may be associated with hyperplastic hepatic nodular lesions in the long term: an analysis of 18 pediatric and young adult patients.

Authors:  Andrew J Woerner; David S Shin; Jeffrey Forris Beecham Chick; Kevin S H Koo; Evelyn K Hsu; Elizabeth R Tang; Eric J Monroe
Journal:  Pediatr Radiol       Date:  2021-03-30

2.  Portosystemic shunt for portal hypertension after Kasai operation in patients with biliary atresia.

Authors:  Toru Shimizu; Albert Shun; Gordon Thomas
Journal:  Pediatr Surg Int       Date:  2020-11-17       Impact factor: 1.827

Review 3.  Rex Shunt for Extra-Hepatic Portal Venous Obstruction in Children.

Authors:  Jinshan Zhang; Long Li
Journal:  Children (Basel)       Date:  2022-02-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.